Advanced Filters
noise

A, Concord N Clinical Trials

A listing of A, Concord N clinical trials actively recruiting patients volunteers.

Found 10,489 clinical trials
J Joshua Smith, Dr

A Phase 2 Study of Vosoritide in Children with Idiopathic Short Stature

The purpose of this study is to evaluate i) the effect of multiple doses of vosoritide and ii) the effect of the therapeutic dose of vosoritide compared to human growth hormone (hGH), in children with idiopathic short stature (ISS).

3 - 10 years of age All Phase 2

A Study of SHR-3821 Injection in Subjects With Advanced Solid Tumors

This is an open label, multi-center, multiple dose Phase I study to evaluate the safety, tolerability, pharmacokinetics and efficacy of SHR-3821 injection in subjects with advanced solid tumors.

18 - 75 years of age All Phase 1
L Lucia Druzianic

A Study to Evaluate Single-dose of HB0043 in Healthy Adult Participants

The aim of this study is to investigate the safety and tolerability of HB0043 in healthy subjects following single-dose.

18 - 55 years of age All Phase 1
R Rafael Bahamonde

Modulation of Motor Learning Via tDCS in a Dexterous Video Game Task

The purpose of this study is to determine whether "transcranial direct current stimulation" (tDCS) is effective in enhancing learning of complex motor tasks of precision and accuracy that require the simultaneous coordination of both hands. The study will utilize a between-subjects, SHAM controlled design. Subjects will be randomly selected to …

18 - 45 years of age All Phase N/A
p project manager

A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis

Allergic rhinitis (AR) is a non-infectious chronic inflammatory disease of the nasal mucosa mainly mediated by immunoglobulin E after exposure to allergens in atopic individuals. The typical symptoms of AR are paroxysmal sneezing, watery rhinorrhea, itching, and nasal congestion, which may be accompanied by ocular symptoms, including eye itching, tearing, …

18 - 75 years of age All Phase 3
T Tianshu Liu

A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients

This study includes two parts:Part 1: SSGJ-707 (different dosing regimens) in combination with chemotherapy for first-line treatment of metastatic colorectal cancer.Part 2: SSGJ-707 in combination with chemotherapy versus bevacizumab in combination with chemotherapy for first-line treatment of metastatic colorectal cancer.

18 - 75 years of age All Phase 2
Y Yongjun Wang, MD

A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke

MT200605 is an agonist of the receptor tyrosine kinase B (TrkB). It exerts brain-derived neurotrophic factor (BDNF)-like effects, protecting the structure and function of neural tissues in the brain. Simultaneously, it enhances ATP synthesis in the mitochondria of the striatum and bolsters antioxidant and free radical-scavenging capabilities. MT200605 is anticipated …

18 - 80 years of age All Phase 2
X Xiaohong Han

A Safety and Tolerability Study of BPR-30221616 Injection in Healthy Subjects

The purpose of this study is to determine the safety, tolerability, pharmacokinetics、 pharmacodynamics and immunogenicity of BPR-30221616 in healthy subjects.

18 - 65 years of age All Phase 1
K Kunta Devi Pun, PhD

Effect of a Mobile Health Intervention on Birth Outcome and Infant Health

Globally, neonatal and infant mortality persist as challenging concerns, paralleled by a notable prevalence of low birth weight, preterm birth, and challenges in child growth and development. Some of the factors contributing to these issues include poor maternal health and nutrition, maternal smoking, and insufficient maternal awareness. Despite global efforts …

18 years of age Female Phase N/A
N Nancy Kuntz, MD

A Study to Assess the Safety of ARGX-213 in Healthy Volunteers

This study aims to assess the safety of ARGX-213 in healthy adults. Another aim is to measure the amount of ARGX-213 in the blood over time to learn how it moves through the body and acts in the body. The participants will remain in the study for approximately up to …

18 - 65 years of age All Phase 1

Simplify language using AI